CRISPR technology allows for genome editing using a prokaryotic immune system called CRISPR/Cas. The system works by adapting spacers from viral DNA, producing CRISPR RNA, and targeting matching sequences. It is being applied in industry to make bacterial cultures virus-resistant, in labs for genetic engineering, and in medicine for treating genetic diseases and developing more specific antibiotics.